Position in CLYM
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$10,199,874
+$8,055,832 QoQ
Shares Held
782,199
+149.9% QoQ
Ownership
1.36%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#19
of 108 holders
Holding Since
Sep 2021
20 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CLYM Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026GEODE CAPITAL MANAGEMENT, LLC holds $21,877,515,789 across 520 Biotechnology names. CLYM ranks #188 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
6,017,848 | $2,989,245,636 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,625,810 | $1,637,297,566 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,635,840 | $793,466,914 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
3,942,676 | $738,384,360 | |
| 5 | MRNA |
Moderna, Inc.
|
9,710,335 | $680,014,759 | |
| 6 | INCY |
Incyte Corp
|
4,750,735 | $538,543,319 | |
| 7 | RPRX |
Royalty Pharma plc
|
8,058,048 | $451,814,751 | |
| 8 | INSM |
INSMED Inc
|
4,220,155 | $449,952,925 |
All Filings in CLYM
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $10,199,874 | 782,199 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $2,144,042 | 312,999 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $1,243,024 | 310,756 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $626,558 | 311,721 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $386,533 | 311,721 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $822,048 | 673,811 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $1,189,495 | 660,831 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $3,315,100 | 651,297 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $1,220,054 | 171,597 | Shares | Defined | 2024-08-09 | |
| 2024-03-31 | $182,555 | 66,626 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $179,890 | 66,626 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $175,226 | 66,626 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $179,239 | 64,014 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $185,640 | 64,014 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $234,931 | 64,014 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $207,168 | 64,139 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $193,699 | 64,139 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $948,246 | 113,021 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $1,209,929 | 115,672 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $1,382,733 | 76,904 | Shares | Defined | 2021-11-12 | |
| No filing history on record for this holder in this stock. | ||||||